FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 4183172 · Received October 17, 2014

Report

Report Number
2032227-2014-40069
Event Type
Malfunction
Date Received
October 17, 2014
Date of Event
September 19, 2014
Report Date
September 19, 2014
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. THE DEVICE HAS BEEN RETURNED, BUT NOT YET EVALUATED. FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.(B)(4).

Additional Manufacturer Narrative · 1

A CRACKED RESERVOIR TUBE LIP, MINOR SCRATCHES ON THE DISPLAY WINDOW, AND A SCRATCHED CASE WERE NOTED DURING THE VISUAL INSPECTION. THE INSULIN PUMP WAS MONITORED AND ALL OPERATING CURRENTS TESTED WITHIN SPECIFICATION. NO FAILED BATTERY TEST ALARM WAS NOTED.

Description of Event or Problem · 1

NO BLOOD GLUCOSE LEVELS WERE PROVIDED. THE CUSTOMER REPORTED A FAILED BATTERY TEST ALARM FROM THE INSULIN PUMP. THE CUSTOMER REPORTED USING A USED BUT PROPERLY FUNCTIONING BATTERY FOR THE INSULIN PUMP. TROUBLESHOOTING WAS DONE. THE CUSTOMER WAS ADVISED TO USE NEW AAA ALKALINE BATTERIES FOR THE INSULIN PUMP. A NEW BATTERY WAS INSTALLED ON THE INSULIN PUMP. THE CUSTOMER RECEIVED ANOTHER FAILED BATTERY TEST FROM THE INSULIN PUMP. THE CUSTOMER WAS ADVISED THAT THE INSULIN PUMP WOULD NEED TO BE REPLACED. THE CUSTOMER WAS ADVISED TO DISCONTINUE USE OF THE INSULIN PUMP AND TO REVERT TO A BACK-UP PLAN PER THE HEALTH CARE PROVIDER'S INSTRUCTION. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
660772 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-523LNAS

Patients

Seq Age Sex Outcome Treatment
1 49 YR